MXPA04008847A - Complejo multifuncional para dirigir la fagocitosis especifica de un agente objetivo. - Google Patents

Complejo multifuncional para dirigir la fagocitosis especifica de un agente objetivo.

Info

Publication number
MXPA04008847A
MXPA04008847A MXPA04008847A MXPA04008847A MXPA04008847A MX PA04008847 A MXPA04008847 A MX PA04008847A MX PA04008847 A MXPA04008847 A MX PA04008847A MX PA04008847 A MXPA04008847 A MX PA04008847A MX PA04008847 A MXPA04008847 A MX PA04008847A
Authority
MX
Mexico
Prior art keywords
complex
component
target
directed
agent
Prior art date
Application number
MXPA04008847A
Other languages
English (en)
Spanish (es)
Inventor
Pinchasov Yosef
Original Assignee
Yamit Biotechnologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamit Biotechnologies Ltd filed Critical Yamit Biotechnologies Ltd
Publication of MXPA04008847A publication Critical patent/MXPA04008847A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1275—Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
MXPA04008847A 2002-03-10 2003-03-10 Complejo multifuncional para dirigir la fagocitosis especifica de un agente objetivo. MXPA04008847A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL148598A IL148598A (en) 2002-03-10 2002-03-10 Multifunctional complex for targeting specific phagocytosis of a target agent and a composition comprising it
PCT/IL2003/000196 WO2003076471A2 (en) 2002-03-10 2003-03-10 A multifunctional complex for targeting specific phagocytosis of a target agent

Publications (1)

Publication Number Publication Date
MXPA04008847A true MXPA04008847A (es) 2005-06-17

Family

ID=27799844

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04008847A MXPA04008847A (es) 2002-03-10 2003-03-10 Complejo multifuncional para dirigir la fagocitosis especifica de un agente objetivo.

Country Status (8)

Country Link
US (1) US20040258664A1 (https=)
EP (1) EP1485414A2 (https=)
JP (1) JP2006504619A (https=)
AU (1) AU2003212633A1 (https=)
CA (1) CA2478415A1 (https=)
IL (1) IL148598A (https=)
MX (1) MXPA04008847A (https=)
WO (1) WO2003076471A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2339436A1 (fr) * 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
US20120164135A1 (en) * 2008-12-19 2012-06-28 Kabushiki Kaisha Saiwai Medix Method for preparing comprehensive anti-surface antibody using microorganism immobilized as antigen with protein crosslinking and immobilization reagent
JP5439127B2 (ja) * 2009-11-13 2014-03-12 株式会社さいわいメディカル 乾癬又はアトピー性皮膚炎治療剤
WO2013009843A1 (en) * 2011-07-11 2013-01-17 Camas Incorporated Compositions against bacterial toxins
CN103323585B (zh) * 2013-06-06 2015-07-22 广东海大畜牧兽医研究院有限公司 一种检测鱼类无乳链球菌IgM抗体的ELISA试剂盒及其制备方法
US9791440B2 (en) 2013-07-15 2017-10-17 President And Fellows Of Harvard College Assays for antimicrobial activity and applications thereof
US10139409B2 (en) 2013-12-18 2018-11-27 Asahi Kasei Kabushiki Kaisha Method for detecting Streptococcus bacterium contained in milk
JP2017504325A (ja) * 2014-01-14 2017-02-09 インテグレイテッド バイオセラピューティクス，インコーポレイテッド バクテリオシンの細胞壁ターゲティングドメインを用いた細菌感染部位への免疫学的機能のターゲティング方法
CN108623680A (zh) * 2017-03-17 2018-10-09 蒙永祥 复合抗体提取物及其制备方法和应用
EP4480961A1 (en) 2023-06-23 2024-12-25 Consejo Superior De Investigaciones Científicas Pathogen trapping systems and related aquacultural uses
EP4570822A1 (en) 2023-12-15 2025-06-18 Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. Immunizing and/or medical preparation for use in preventing and/or treating inflammatory conditions of cow udder

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01168246A (ja) * 1987-12-24 1989-07-03 Taiyo Kagaku Co Ltd 特異的鶏卵抗体を配合してなる養殖魚用飼料
DE69029873T2 (de) * 1989-05-02 1997-08-07 Abbott Lab Kovalente Kupplung von spezifischen Bindungspartnern an einer Festphase
US6030805A (en) * 1989-05-04 2000-02-29 Normark; Staffan Fibronectin binding protein as well as its preparation
JPH0356426A (ja) * 1989-07-24 1991-03-12 Gifu Meneki Kenkyusho:Kk ウシ乳房炎予防および治療用抗体含有材料
US5064645A (en) * 1990-07-27 1991-11-12 Pisciconsult Developpement Inc. Hyperimmune composition for passive immunization of fishes against furunculosis caused by Aeromonas salmonicida
GB9112310D0 (en) * 1991-06-07 1991-07-24 United Kingdom Government Fish vaccine
US5585098A (en) * 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
US5700465A (en) * 1994-01-05 1997-12-23 American Cyanamid Company Bovine serum and bovine IgG as preventives and therapeutives for bovine mastitis
US6143559A (en) * 1996-11-18 2000-11-07 Arch Development Corporation Methods for the production of chicken monoclonal antibodies
AU2001274888A1 (en) * 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
US20050196755A1 (en) * 2000-11-17 2005-09-08 Maurice Zauderer In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
DE10123505A1 (de) * 2001-05-15 2002-11-28 Wolfgang Bergter Immunkonjugate aus Eidotter-Antikörpern (lgY), deren Konfektionierung und Anwendung in Diagnostik und Therapie

Also Published As

Publication number Publication date
WO2003076471A3 (en) 2004-01-08
IL148598A (en) 2008-04-13
WO2003076471A2 (en) 2003-09-18
JP2006504619A (ja) 2006-02-09
CA2478415A1 (en) 2003-09-18
AU2003212633A1 (en) 2003-09-22
IL148598A0 (en) 2002-09-12
US20040258664A1 (en) 2004-12-23
EP1485414A2 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
Kovacs-Nolan et al. Avian egg antibodies: basic and potential applications
US5585098A (en) Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
KR101785120B1 (ko) 병적 장애의 치료 및/또는 예방에 이용되는 항-ｌｐｓ 풍부한 면역글로블린 조제물
Chalghoumi et al. Hen egg yolk antibodies (IgY), production and use for passive immunization against bacterial enteric infections in chicken: a review
AU729502B2 (en) Oral administration of chicken yolk antibodies to treat disease
Watson Immunological functions of the mammary gland and its secretion-comparative review
JPH08231424A (ja) トリの抗体を用いた哺乳動物の受動免疫化
JP2008179634A (ja) グラム陽性細菌のリポタイコ酸に特異的なオプソニン性モノクローナルおよびキメラ抗体
JP2002501526A (ja) 乳汁における免疫グロブリンａの生成方法
KR102047784B1 (ko) 송아지 소화기성 질병의 예방 또는 치료용 난황항체 제조방법, 이에 의해 제조된 난황항체 및 이의 용도
US20020044942A1 (en) Transfer factor composition and process for producing same
MXPA04008847A (es) Complejo multifuncional para dirigir la fagocitosis especifica de un agente objetivo.
EP2500034A1 (en) Therapeutic agent for psoriasis or atopic dermatitis
KR102148503B1 (ko) 돼지 소화기성 질병의 예방 또는 치료용 난황항체 제조방법, 이에 의해 제조된 난황항체 및 이의 용도
Akita et al. Neutralization of enterotoxigenic escherichia coli heat‐labile toxin by chicken egg yolk immunoglobulin Y and its antigen‐binding fragments
EP0527971B1 (en) Composition and method for immunostimulation in mammals
US20110129479A1 (en) Immunogen selection directed in immunoglobulin packages in plasma and colostrum and method of making and using same
JPH08504167A (ja) スタフィロコーカス感染の予防及び処理のための指図されたヒト免疫グロブリン
JP2006504619A5 (https=)
US20070264264A1 (en) Method and composition for conferring immunity in mammals
Kaplin et al. IgY-Technologies. Birds Yolk Antibodies
Chitra Egg yolk antibodies (IgY) and its therapeutic uses for human and animal health-A review
US7244427B2 (en) Isolated bovine IgG heavy chain protein and its use as an antimicrobial
US10278404B2 (en) Immunized camel milk-based composition for the treatment or prevention of gastrointestinal infections
Watson Synergism between antibody and neutrophils in the ruminant mammary gland

Legal Events

Date Code Title Description
FA Abandonment or withdrawal